# Donor Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia in Remission

> **NCT00101140** · PHASE2 · WITHDRAWN · sponsor: **Eastern Cooperative Oncology Group**

## Conditions studied

- Adult Acute Erythroid Leukemia
- Adult Acute Monoblastic and Acute Monocytic Leukemia
- Adult Acute Myeloid Leukemia

## Interventions

- **DRUG:** anti-thymocyte globulin
- **DRUG:** fludarabine phosphate
- **DRUG:** thiotepa
- **PROCEDURE:** biological therapy
- **PROCEDURE:** bone marrow ablation with stem cell support
- **PROCEDURE:** chemotherapy
- **PROCEDURE:** non-specific immune-modulator therapy
- **PROCEDURE:** peripheral blood stem cell transplantation
- **PROCEDURE:** radiation therapy

## Key facts

- **NCT ID:** NCT00101140
- **Lead sponsor:** Eastern Cooperative Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2017-10-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00101140

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00101140, "Donor Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia in Remission". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00101140. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*